{
    "Trade/Device Name(s)": [
        "AllTest Fentanyl Urine Test Cassette"
    ],
    "Submitter Information": "Hangzhou Alltest Biotech Co., Ltd.",
    "510(k) Number": "K233417",
    "Predicate Device Reference 510(k) Number(s)": [
        "K231698"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NGL"
    ],
    "Summary Letter Date": "October 26, 2023",
    "Summary Letter Received Date": "October 10, 2023",
    "Submission Date": "October 6, 2023",
    "Regulation Number(s)": [
        "21 CFR 862.3650"
    ],
    "Regulation Name(s)": [
        "Opiate test system"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Fentanyl"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [
        ""
    ],
    "Instrument(s)/Platform(s)": [
        ""
    ],
    "Method(s)/Technology(ies)": [
        "Competitive binding",
        "Lateral flow immunochromatographic assay"
    ],
    "Methodologies": [
        "Immunochromatography",
        "Antigen-antibody immunochemistry"
    ],
    "Submission Type(s)": [
        "Cassette"
    ],
    "Document Summary": "FDA 510(k) summary for AllTest Fentanyl Urine Test Cassette for qualitative detection of fentanyl in urine using competitive lateral flow immunoassay",
    "Indications for Use Summary": "Qualitative detection of fentanyl in human urine at a 1 ng/mL cutoff; for in vitro diagnostic use only; provides preliminary results, confirmatory testing (GC/MS or LC/MS) required",
    "fda_folder": "Toxicology"
}